David J. Davido

1.0k total citations
37 papers, 819 citations indexed

About

David J. Davido is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, David J. Davido has authored 37 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 21 papers in Immunology and 11 papers in Genetics. Recurrent topics in David J. Davido's work include Herpesvirus Infections and Treatments (32 papers), Cytomegalovirus and herpesvirus research (12 papers) and Virus-based gene therapy research (11 papers). David J. Davido is often cited by papers focused on Herpesvirus Infections and Treatments (32 papers), Cytomegalovirus and herpesvirus research (12 papers) and Virus-based gene therapy research (11 papers). David J. Davido collaborates with scholars based in United States, United Kingdom and Germany. David J. Davido's co-authors include Heba H. Mostafa, Priscilla A. Schaffer, David A. Leib, Lynda A. Morrison, Mirna Perusina Lanfranca, Stuart J. Macdonald, Miles Smith, Chris Boutell, Clinton D. Kemp and Jennifer A. Isler and has published in prestigious journals such as PLoS ONE, Journal of Virology and International Journal of Molecular Sciences.

In The Last Decade

David J. Davido

36 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Davido United States 19 635 335 233 172 128 37 819
Mary Jane Nicholl United Kingdom 13 694 1.1× 358 1.1× 223 1.0× 215 1.3× 97 0.8× 14 845
Ryan Hagglund United States 9 470 0.7× 254 0.8× 238 1.0× 172 1.0× 70 0.5× 9 587
Naoto Koyanagi Japan 18 520 0.8× 267 0.8× 347 1.5× 118 0.7× 55 0.4× 44 805
Eve Diefenbach Australia 12 353 0.6× 273 0.8× 285 1.2× 94 0.5× 112 0.9× 19 775
Martin I. Muggeridge United States 14 627 1.0× 252 0.8× 96 0.4× 249 1.4× 122 1.0× 20 729
Jaya Rajamani United States 17 536 0.8× 195 0.6× 136 0.6× 100 0.6× 135 1.1× 23 679
Anne Binz Germany 14 534 0.8× 159 0.5× 129 0.6× 118 0.7× 54 0.4× 16 626
Andrea D. Lipińska Poland 14 299 0.5× 204 0.6× 232 1.0× 85 0.5× 44 0.3× 32 611
Tracy Jo Pasieka United States 13 379 0.6× 240 0.7× 118 0.5× 68 0.4× 43 0.3× 15 567
Jesse H. Arbuckle United States 13 570 0.9× 173 0.5× 219 0.9× 93 0.5× 70 0.5× 21 901

Countries citing papers authored by David J. Davido

Since Specialization
Citations

This map shows the geographic impact of David J. Davido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Davido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Davido more than expected).

Fields of papers citing papers by David J. Davido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Davido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Davido. The network helps show where David J. Davido may publish in the future.

Co-authorship network of co-authors of David J. Davido

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Davido. A scholar is included among the top collaborators of David J. Davido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Davido. David J. Davido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bejan, Daniel S., Yating Chen, Ellen L. Suder, et al.. (2025). PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses. mBio. 16(10). e0229925–e0229925. 2 indexed citations
2.
Kashipathy, M.M., Philip Gao, David K. Johnson, et al.. (2024). HSV ‐1 ICP0 dimer domain adopts a novel β‐barrel fold. Proteins Structure Function and Bioinformatics. 92(7). 830–841.
3.
Davido, David J., et al.. (2023). Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 0 (ICP0) Targets of Ubiquitination during Productive Infection of Primary Adult Sensory Neurons. International Journal of Molecular Sciences. 24(3). 2931–2931. 6 indexed citations
4.
5.
McDonald, Peter R., et al.. (2021). Simple and rapid high-throughput assay to identify HSV-1 ICP0 transactivation inhibitors. Antiviral Research. 194. 105160–105160. 4 indexed citations
6.
Boutell, Chris & David J. Davido. (2015). A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro. Methods. 90. 3–7. 5 indexed citations
7.
Smith, Miles, Erica T. Goddard, Mirna Perusina Lanfranca, & David J. Davido. (2013). hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling. PLoS ONE. 8(3). e58233–e58233. 15 indexed citations
8.
Wang, Hong, David J. Davido, & Lynda A. Morrison. (2013). HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice. Virus Research. 173(2). 436–440. 34 indexed citations
9.
Mostafa, Heba H., Thornton W. Thompson, & David J. Davido. (2012). N-Terminal Phosphorylation Sites of Herpes Simplex Virus 1 ICP0 Differentially Regulate Its Activities and Enhance Viral Replication. Journal of Virology. 87(4). 2109–2119. 19 indexed citations
10.
Macdonald, Stuart J., Heba H. Mostafa, Lynda A. Morrison, & David J. Davido. (2012). Genome Sequence of Herpes Simplex Virus 1 Strain McKrae. Journal of Virology. 86(17). 9540–9541. 33 indexed citations
11.
Smith, Miles, Adam M. Bayless, Erica T. Goddard, & David J. Davido. (2011). CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β. Antiviral Research. 91(3). 259–266. 16 indexed citations
12.
Bayless, Adam M., et al.. (2010). Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replicationin vivo. Journal of NeuroVirology. 16(5). 405–409. 8 indexed citations
13.
Slusser, Joyce G., et al.. (2009). A flow cytometric assay for the study of E3 ubiquitin ligase activity. Cytometry Part A. 75A(7). 634–641. 1 indexed citations
14.
Kushnir, Anna, David J. Davido, & Priscilla A. Schaffer. (2009). Role of Nuclear Factor Y in Stress-Induced Activation of the Herpes Simplex Virus Type 1 ICP0 Promoter. Journal of Virology. 84(1). 188–200. 26 indexed citations
15.
Boutell, Chris, et al.. (2008). Herpes Simplex Virus Type 1 ICP0 Phosphorylation Mutants Impair the E3 Ubiquitin Ligase Activity of ICP0 in a Cell Type-Dependent Manner. Journal of Virology. 82(21). 10647–10656. 24 indexed citations
16.
Davido, David J., Frank Richter, Frank Boxberger, et al.. (2001). Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation. European Journal of Cancer Prevention. 10(4). 313–321. 22 indexed citations
17.
Halford, William P., Clinton D. Kemp, Jennifer A. Isler, David J. Davido, & Priscilla A. Schaffer. (2001). ICP0, ICP4, or VP16 Expressed from Adenovirus Vectors Induces Reactivation of Latent Herpes Simplex Virus Type 1 in Primary Cultures of Latently Infected Trigeminal Ganglion Cells. Journal of Virology. 75(13). 6143–6153. 107 indexed citations
18.
Davido, David J. & David A. Leib. (1998). Analysis of the basal and inducible activities of the ICPO promoter of herpes simplex virus type 1.. Journal of General Virology. 79(9). 2093–2098. 19 indexed citations
19.
Davido, David J. & David A. Leib. (1996). Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation. Journal of General Virology. 77(8). 1853–1863. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Jane Nicholl Breakdown of academic impact, for papers by Ryan Hagglund Breakdown of academic impact, for papers by Naoto Koyanagi Breakdown of academic impact, for papers by Eve Diefenbach Breakdown of academic impact, for papers by Martin I. Muggeridge Breakdown of academic impact, for papers by Jaya Rajamani Breakdown of academic impact, for papers by Anne Binz Breakdown of academic impact, for papers by Andrea D. Lipińska Breakdown of academic impact, for papers by Tracy Jo Pasieka Breakdown of academic impact, for papers by Jesse H. Arbuckle
Rankless by CCL
2026